Regulation & legislation

Martek reaps regulatory omega-3 benefits

Martek reaps regulatory omega-3 benefits

By Shane Starling in Brussels

DHA omega-3 is one of the few ingredients to benefit from the European Union nutrition and health claims process so far, and Martek's VP of regulatory affairs, Rodney Gray, looks at developments in other regulatory changes that have affected the...

Kemin and DSM commit to article 13.5 lutein submission

Kemin and DSM commit to article 13.5 lutein submission

By Shane Starling

Leading lutein suppler Kemin Health will resubmit a lutein dossier under article 13.5 of the European Union nutrition and health claims regulation, after EFSA last week rejected an article 13.1 lutein-eye health submission.

Lack of established risk factors hampers research: Cantox

Lack of established risk factors hampers research: Cantox

By Shane Starling in Brussels

Cantox Health Science International’s Canadian-based, Food and Nutrition associate director, Kathy Musa-Velosa PhD, tells Shane Starling about how risk factors and biomarkers are being used as measures for disease reduction health claims.

Overview: The (seemingly) unstoppable antioxidant powerhouse

Special edition: Antioxidants

Overview: The (seemingly) unstoppable antioxidant powerhouse

By Shane Starling

In the first instalment of this antioxidants special NutraIngredients scans a diverse global market that has barely been dented by the recession and continues to flourish amid consumer understanding that is often little more than surface deep.

EFSA rejects Danone’s infant immunity prebiotic claim

EFSA health claim opinion

EFSA rejects Danone’s infant immunity prebiotic claim

By Shane Starling

Danone Baby Nutrition says the European Food Safety Authority (EFSA) failed to engage in “direct scientific dialogue” in the lead-up to the agency’s scientists handing it a negative opinion for a prebiotic-infant immunity health claim in December.

Will nutrient profiles ever be confirmed?

Will nutrient profiles ever be confirmed?

By Jess Halliday

How usable are the health claims that have already been approved? First, companies need to see if there is any wiggle room around EFSA’s scientific language. Then, the thorny nutrient profiling is unclear. According to a food lawyer, if agreement can’t...

Health claims threaten prebiotic innovation: Scientist

Dispatches from the NI Health Claims 2010 conference

Health claims threaten prebiotic innovation: Scientist

By Stephen Daniells

Concerns abound that the approach of the European Food Safety Authority towards health claims may stifle innovation and science, none more so than for prebiotics, says a leading researcher.

Trade groups gain long awaited EC health claims hearing

Dispatches from the NI Health Claims 2010 conference

Trade groups gain long awaited EC health claims hearing

By Stephen Daniells

Europe's leading trade groups are set for a meeting with the European Commission to discuss their concerns over the health claims assessment, and EFSA's reluctance to engage in dialogue.

Provexis tomato extract claim approved by EC

Provexis tomato extract claim approved by EC

By Shane Starling

More than six months after receiving a positive health claim opinion from the European Food Safety Authority (EFSA) linking its tomato extract to blood circulation benefits, UK biotech firm Provexis has been handed final claim wording by the European...

Free speech argument a

Dispatches from the NI Health Claims 2010 conference

Free speech argument a "possible avenue": UK lawyer

By Stephen Daniells

Making claims based on non-conclusive but still substantial science is a "possible avenue" since denying a 'maybe' claim may challenge free speech rights, says a UK lawyer.

Follow us

Products

View more

Webinars